Internal standards in regulated bioanalysis: putting in place a decision-making process during method development
Related Experiment Video
Updated: Jan 5, 2026

Multi-step Preparation Technique to Recover Multiple Metabolite Compound Classes for In-depth and Informative Metabolomic Analysis
Published on: July 11, 2014
Michael J Wright1, Robert Wheller1, Geoff Wallace1
1LGC Limited, Drug Development Solutions, Fordham, Cambridgeshire, CB7 5WW, UK.
Abstract:
It is common practice to utilize an internal standard (IS) to minimize variance in bioanalytical assays employing liquid chromatography coupled to mass spectrometry. For assays to be deployed in regulated drug development studies, ensuring the IS will compensate for differences in recovery, liquid handling and ionization efficiency should be determined early in the method development process. In this perspective article, we outline key considerations when selecting an IS and propose experiments to perform within the method development phase to demonstrate suitability of the IS within the assay prior to validation. Finally, a series of case studies will be presented, which illustrate analytical challenges related to internal standardization that we have observed in our laboratory.
Related Concept Videos
Data Validation
Key parameters for method validation include:
Development of Analytical Methods
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Clinically Relevant Drug Product Specifications: Methods of Establishment
Preclinical Development: Overview
Bioequivalence studies: Biowaivers

